INTERNATIONAL BIOTECHNOLOGY TRUST PLC
Portfolio Update as at 31 May 2013
|
Total net assets |
£163.8m |
|
NAV per share |
297.0p |
|
Share price |
258.5p |
|
Total value of unquoted investments |
£25.8m |
|
Total number of portfolio companies |
70 |
|
Cash |
1% NAV |
|
Cash committed and reserved to unquoted investments |
(4.5%) NAV |
Top Ten Holdings
|
Company Name |
% NAV |
|
Gilead Amgen Celgene |
6.9 6.6 6.1 |
|
Alexion |
5.0 |
|
Onyx |
4.2 |
|
Biogen |
3.9 |
|
Aptiv |
3.6 |
|
Insulet |
2.8 |
|
Regeneron |
2.7 |
|
Achillion |
2.4 |
|
|
----------- |
|
Total |
44.2 |
|
Geographical Allocation |
% |
|
United States & Canada |
90 |
|
Europe |
9 |
|
Cash |
1 |
|
|
----------- |
|
Total |
100 |
|
Quoted/Unquoted allocation |
% |
|
Quoted |
83 |
|
Unquoted |
16 |
|
Cash |
1 |
|
|
----------- |
|
Total |
100 |
BNP Paribas Secretarial Services Limited
Company Secretary
25 JUNE 2013